Sonnet BioTherapeutics Holdings, Inc. Announces Adjournment of Special Meeting
Sonnet BioTherapeutics Holdings, Inc. Announces Adjournment of Special Meeting GlobeNewswire November 18, 2025 PRINCETON, N.J., Nov. 18, 2025 (GLOBE NEWSWIRE) — Sonnet BioTherapeutics Holdings, Inc., (NASDAQ: SONN) (“Sonnet” or the “Company”) today announced that it has adjourned its special meeting of stockholders (the “Special Meeting”) in order to provide stockholders additional time within which to […]